Westbourne Investments »

United Therapeutics Corporation shares owned by Westbourne Investments

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Westbourne Investments from 13F filings

Historical chart of Westbourne Investments investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Westbourne Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Westbourne Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $390k 658 592.98

More positions owned by Westbourne Investments

NVIDIA Corporation (NVDA)
Ge Aerospace Com New (GE)
Spdr Series Trust State Street Spd (BIL)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Vertiv Holdings Com Cl A (VRT)
Amazon (AMZN)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Vistra Energy (VST)
Parker-Hannifin Corporation (PH)
Pfizer (PFE)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Westbourne Investments

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Renaissance Technologies
State Street Corporation
Geode Capital Management
Henderson Group
AQR Capital Management
Citadel Advisors
Assetmark
Invesco
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation